0
     

Report Added
Report already added
Global Nuclear Medicine & Radiopharmaceuticals Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Global Nuclear Medicine & Radiopharmaceuticals Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Executive Summary

According to GRD Survey data, the global Nuclear Medicine & Radiopharmaceuticals market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.

This report studies the Nuclear Medicine & Radiopharmaceuticals market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Nuclear Medicine & Radiopharmaceuticals in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Diagnostic
Therapeutic

Market Snapshot, By Application
Oncology
Thyroid
Cardiology
Others

Main Market Players Analyzed in this report, including:
Shanghai Atom Kexing
Jaco
Dongcheng
Ciaeriar
China Isotope & Radiation
Advanced Molecular-imaging Solution

The study objectives of this report are:
To study and analyze the global Nuclear Medicine & Radiopharmaceuticals market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Nuclear Medicine & Radiopharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Nuclear Medicine & Radiopharmaceuticals manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nuclear Medicine & Radiopharmaceuticals market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Nuclear Medicine & Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nuclear Medicine & Radiopharmaceuticals are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Nuclear Medicine & Radiopharmaceuticals Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Nuclear Medicine & Radiopharmaceuticals Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Nuclear Medicine & Radiopharmaceuticals

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Nuclear Medicine & Radiopharmaceuticals Sales Channel and Distributors Analysis
3.3.1 Nuclear Medicine & Radiopharmaceuticals Sales Channel
3.3.2 Nuclear Medicine & Radiopharmaceuticals Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Oncology
3.4.2 Major Buyers in Thyroid
3.5 Nuclear Medicine & Radiopharmaceuticals Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Nuclear Medicine & Radiopharmaceuticals Type Introduction
4.1.1 Diagnostic
4.1.2 Therapeutic
4.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type 2016-2021
4.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type 2016-2021
4.4 Global Nuclear Medicine & Radiopharmaceuticals Price by Type 2016-2021

5 Market Segment: by Application
5.1 Nuclear Medicine & Radiopharmaceuticals Type Introduction
5.1.1 Oncology
5.1.2 Thyroid
5.1.3 Cardiology
5.1.3 Others
5.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application 2016-2021
5.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application 2016-2021
5.4 Global Nuclear Medicine & Radiopharmaceuticals Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Nuclear Medicine & Radiopharmaceuticals Market by Region
6.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Regions
6.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions
6.2 North America Nuclear Medicine & Radiopharmaceuticals Market 2016-2021
6.3 Europe Nuclear Medicine & Radiopharmaceuticals Market 2016-2021
6.4 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market 2016-2021
6.5 South America Nuclear Medicine & Radiopharmaceuticals Market 2016-2021
6.6 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market 2016-2021

7 North America
7.1 North America Nuclear Medicine & Radiopharmaceuticals Market by Country 2016-2021
7.1.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country
7.1.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Nuclear Medicine & Radiopharmaceuticals Market by Country 2016-2021
8.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country
8.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market by Country 2016-2021
9.1.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Country
9.1.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Nuclear Medicine & Radiopharmaceuticals Market by Country 2016-2021
10.1.1 South America Nuclear Medicine & Radiopharmaceuticals Sales by Country
10.1.2 South America Nuclear Medicine & Radiopharmaceuticals Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market by Country 2016-2021
11.1.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country
11.1.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Shanghai Atom Kexing
12.1.1 Shanghai Atom Kexing Company Information
12.1.2 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
12.1.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Shanghai Atom Kexing Key Development
12.2 Jaco
12.2.1 Jaco Company Information
12.2.2 Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
12.2.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Jaco Key Development
12.3 Dongcheng
12.3.1 Dongcheng Company Information
12.3.2 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
12.3.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Dongcheng Key Development
12.4 Ciaeriar
12.4.1 Ciaeriar Company Information
12.4.2 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
12.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Ciaeriar Key Development
12.5 China Isotope & Radiation
12.5.1 China Isotope & Radiation Company Information
12.5.2 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
12.5.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 China Isotope & Radiation Key Development
12.6 Advanced Molecular-imaging Solution
12.6.1 Advanced Molecular-imaging Solution Company Information
12.6.2 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
12.6.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Advanced Molecular-imaging Solution Key Development

13 Global Nuclear Medicine & Radiopharmaceuticals Market Forecast by Region by Type and by Application
13.1 Global Nuclear Medicine & Radiopharmaceuticals Sales, Revenue Forecast 2022-2027
13.2 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Regions
13.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region 2022-2027
13.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region 2022-2027
13.3 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Type
13.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type 2022-2027
13.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type 2022-2027
13.3.3 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Type 2022-2027
13.4 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Application
13.4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application 2022-2027
13.4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application 2022-2027
13.4.3 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Tables

Table 1: Global Nuclear Medicine & Radiopharmaceuticals Production Specifications
Table 2: Drivers in Nuclear Medicine & Radiopharmaceuticals Market
Table 3: Restraints Nuclear Medicine & Radiopharmaceuticals Market
Table 4: Opportunity in Nuclear Medicine & Radiopharmaceuticals Market
Table 5: Comparion of Alternative and Nuclear Medicine & Radiopharmaceuticals
Table 6: Nuclear Medicine & Radiopharmaceuticals Raw Materials Key Suppliers List
Table 7: Nuclear Medicine & Radiopharmaceuticals Distributors List
Table 8: Nuclear Medicine & Radiopharmaceuticals Major Buyers in Oncology
Table 9: Nuclear Medicine & Radiopharmaceuticals Major Buyers in Thyroid
Table 10: Nuclear Medicine & Radiopharmaceuticals Major Buyers in Cardiology
Table 11: Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type 2016-2021
Table 12: Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type 2016-2021
Table 13: Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) by Type 2016-2021
Table 14: Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type 2016-2021
Table 15: Global Nuclear Medicine & Radiopharmaceuticals Price by Type 2016-2021
Table 16: Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application 2016-2021
Table 17: Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application 2016-2021
Table 18: Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) by Application 2016-2021
Table 19: Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application 2016-2021
Table 20: Global Nuclear Medicine & Radiopharmaceuticals Price by Application 2016-2021
Table 21: Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Region 2016-2021
Table 22: Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region 2016-2021
Table 23: Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) by Region 2016-2021
Table 24: Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region 2016-2021
Table 25: North America Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Country 2016-2021
Table 26: North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country 2016-2021
Table 27: North America Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) by Country 2016-2021
Table 28: North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country 2016-2021)
Table 29: Europe Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Country 2016-2021
Table 30: Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country 2016-2021
Table 31: Europe Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) by Country 2016-2021
Table 32: Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country 2016-2021)
Table 37: South America Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Country 2016-2021
Table 38: South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country 2016-2021
Table 39: South America Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) by Country 2016-2021
Table 40: South America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country 2016-2021)
Table 45 Shanghai Atom Kexing Company Information
Table 46 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
Table 47 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Jaco Company Information
Table 49 Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
Table 50 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Dongcheng Company Information
Table 52 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
Table 53 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Ciaeriar Company Information
Table 55 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
Table 56 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 China Isotope & Radiation Company Information
Table 58 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
Table 59 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Advanced Molecular-imaging Solution Company Information
Table 61 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolio, Specification and Application
Table 62 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Nuclear Medicine & Radiopharmaceuticals Picture
Figure 2: Global Nuclear Medicine & Radiopharmaceuticals Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Nuclear Medicine & Radiopharmaceuticals Supply Chain Analysis
Figure 5: Nuclear Medicine & Radiopharmaceuticals Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Diagnostic
Figure 7: Product Picture of Therapeutic
Figure 8: Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type, 2020
Figure 9: Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type, 2020
Figure 10: Nuclear Medicine & Radiopharmaceuticals in Oncology
Figure 11: Global Nuclear Medicine & Radiopharmaceuticals Market: Oncology 2016-2021
Figure 12: Nuclear Medicine & Radiopharmaceuticals in Thyroid
Figure 13: Global Nuclear Medicine & Radiopharmaceuticals Market: Thyroid 2016-2021
Figure 14: Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application, 2020
Figure 15: Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application, 2020
Figure 16: Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region 2016-2021
Figure 17: Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region 2016-2021
Figure 18: North America Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 19: North America Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 20: Europe Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 21: Europe Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 24: South America Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 25: South America Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 28: North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country, 2020
Figure 29: North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country, 2020
Figure 30: United States Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 31: United States Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 32: Canada Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 33: Canada Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 35: Mexico Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 36: Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country, 2020
Figure 37: Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country, 2020
Figure 38: Germany Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 39: Germany Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 40: France Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 41: France Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 42: UK Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 43: UK Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 44: Italy Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 45: Italy Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 46: Russia Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 46: Russia Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 47: Spain Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 48: Spain Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country, 2020
Figure 50: Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country, 2020
Figure 51: China Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 52: China Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 53: Japan Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 54: Japan Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 55: Korea Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 56: Korea Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 59: India Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 60: India Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 61: Australia Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 62: Australia Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 63: South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country, 2020
Figure 64: South America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country, 2020
Figure 65: Brazil Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 66: Brazil Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 68: Argentina Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 70: Colombia Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country, 2020
Figure 73: Turkey Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 74: Turkey Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Status 2016-2021
Figure 78: South Africa Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) Status 2016-2021
Figure 79: Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 80: Jaco Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 81: Dongcheng Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 82: Ciaeriar Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 83: China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 84: Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Globally (2019-2021)
Figure 89: Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Forecast (2022-2027)
Figure 90: Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) Forecast (2022-2027)

Report Title: Global Nuclear Medicine & Radiopharmaceuticals Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2022 What's Next for Vietnam Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Vietnam Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Venezuela Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Venezuela Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for US Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for US Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Uruguay Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Uruguay Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for United Arab Emirates Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for United Arab Emirates Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Ukraine Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2022 What's Next for Ukraine Diagnostics Market?-- Supplier Shares, Strategies, Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM